Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment. | Genome Biol | 2022 | 36550535 | PubTator, text mining | PubMed |
| NAFLD and HBV interplay - related mechanisms underlying liver disease progression. | Front Immunol | 2022 | 36544761 | PubTator, text mining | PubMed |
| Re-understanding and focusing on normoalbuminuric diabetic kidney disease. | Front Endocrinol (Lausanne) | 2022 | 36531487 | PubTator, text mining | PubMed |
| Biomarkers of gut injury in neonates - where are we in predicting necrotising enterocolitis? | Front Pediatr | 2022 | 36518779 | PubTator, text mining | PubMed |
| Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation. | Clin Appl Thromb Hemost | 2022 | 36514257 | PubTator, text mining | PubMed |
| Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives. | Front Endocrinol (Lausanne) | 2022 | 36506068 | PubTator, text mining | PubMed |
| New Biomarkers in Early Diagnosis of Acute Kidney Injury in Children. | Avicenna J Med Biotechnol | 2022 | 36504568 | PubTator, text mining | PubMed |
| Crosstalk between Resveratrol and Gut Barrier: A Review. | Int J Mol Sci | 2022 | 36499603 | PubTator, text mining | PubMed |
| Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review. | J Blood Med | 2022 | 36467279 | PubTator, text mining | PubMed |
| What role for cellular metabolism in the control of hepatitis viruses? | Front Immunol | 2022 | 36466918 | PubTator, text mining | PubMed |
| Low dimensional nanomaterials for treating acute kidney injury. | J Nanobiotechnology | 2022 | 36456976 | PubTator, text mining | PubMed |
| Urinary extracellular vesicles signature for diagnosis of kidney disease. | iScience | 2022 | 36439984 | PubTator, text mining | PubMed |
| Imaging features of β-catenin-activated hepatocellular adenoma with weak β-catenin activation: A rare case report. | Acta Radiol Open | 2022 | 36439281 | PubTator, text mining | PubMed |
A comparison of the utility of the urine dipstick and urine protein-to-creatinine ratio for predicting microalbuminuria in patients with non-diabetic lifestyle-related diseases -a comparison with diabetes. | BMC Nephrol | 2022 | 36434544 | PubTator, text mining | PubMed |
| MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities. | Cell Death Dis | 2022 | 36433941 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Could Near Infrared Spectroscopy (NIRS) be the new weapon in our fight against Necrotising Enterocolitis? | Front Pediatr | 2022 | 36425397 | PubTator, text mining | PubMed |
| Early renal structural changes and potential biomarkers in diabetic nephropathy. | Front Physiol | 2022 | 36425298 | PubTator, text mining | PubMed |
| Prenatal Metal Exposures and Associations with Kidney Injury Biomarkers in Children. | Toxics | 2022 | 36422900 | PubTator, text mining | PubMed |
| LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. | Cell Death Dis | 2022 | 36418856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=33